Creation of a Patient Database for Silicon Patient Simulation, Glucose Sensor Variability and Pharmacokinetic Study of Debiotech Jewelpump
NCT01640223 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2014-10-27
Summary
The aim this study is the acquisition and management of a data base for the development of the glycaemic regulation algorithms. This database will integrate the measures of blood glucose and the glycaemia level of the Dexcom sensor on a regular time, the injections of insulin delivered by Debiotech JewelPUMP and the level of insulin in the blood. This database will also contain the bolus of insulin injected at meals and the content of meals, the reduction insulin level during physical activity and the quantification of this physical activity. A study will also be conducted to compare the pharmacokinetics of a bolus of insulin identical with the JewelPUMP either the usual pump of the patient.
Conditions
Interventions
- DEVICE
-
Dexcom7
patients will wear 2 Dexcom sensors 3 days before hospitalization.
- DEVICE
-
Dexcom7
patients will wear 2 Dexcom sensor one day before hospitalization
Sponsors & Collaborators
-
Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète
lead OTHER
Principal Investigators
-
Guillaume CHARPENTIER, MD · Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète
-
Bruno GUERCI, MD PHD · Central Hospital, Nancy, France
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-03-31
- Primary Completion
- 2012-10-31
- Completion
- 2012-10-31
Countries
- France
Study Locations
More Related Trials
-
Diabetes Closed-Loop Project 6 (DCLP6): Fully Automated Closed-Loop Control in Type 1 Diabetes Using Meal Anticipation
NCT04877730 ·Status: COMPLETED ·Phase: NA
-
Observational Study of the Use of DBLG1 System in Real Life
NCT04749693 ·Status: RECRUITING
-
Diabeloop WP6.2 : Crossover Evaluation of Glycemic Control
NCT02627911 ·Status: COMPLETED ·Phase: PHASE2
-
Impact of the Mylife CamAPS FX System With the DEXCOM G6 Sensor on T1D Patients in France
NCT07048795 ·Status: RECRUITING
-
Early Feasibility Evaluation of the UniBE Hybrid Closed-loop Insulin Delivery System in Type 1 Diabetes: UBLoop-Genesis
NCT07087340 ·Status: RECRUITING ·Phase: NA
-
Study of Insulin Pump in Prevention of Low Glucose Events in Adults With Type 1 Diabetes at Risk of Severe Hypoglycemia
NCT02657213 ·Status: COMPLETED ·Phase: NA
-
Diabeloop WP7 : Crossover Evaluation of the Safety and the Efficacy of Artificial Pancreas Diabeloop (WP7)
NCT02987556 ·Status: COMPLETED ·Phase: NA
-
The Impact of Hybrid Closed-loop Insulin Delivery in Type 1 Diabetes on Glycemic Control and PROMs
NCT04414280 ·Status: ACTIVE_NOT_RECRUITING
-
The International Diabetes Closed Loop (iDCL) Trial: Clinical Acceptance of the Artificial Pancreas (DCLP3 Extension)
NCT03591354 ·Status: COMPLETED ·Phase: NA
-
Feasibility of Automated Insulin Delivery With an Interoperable Algorithm Using an Alternative Insulin Pump
NCT05299177 ·Status: TERMINATED ·Phase: NA
-
Initial Testing of the Diabeloop Algorithm in T1D Patients on Pump Therapy Over the Prandial Period and Physical Activity.
NCT01754181 ·Status: COMPLETED ·Phase: PHASE3
-
Real-life Data From Diabetic Patients on Closed-loop Pumps
NCT05418699 ·Status: COMPLETED
-
An Outpatient Pump Shutoff Pilot Feasibility and Safety Study
NCT01736930 ·Status: COMPLETED ·Phase: PHASE2
-
Cross-over Study to Evaluate the Safety and Efficacy of Night Closed-loop Control Using the MD-Logic Automated Insulin Delivery System Compared to Sensor Augmented Pump Therapy in Poorly Controlled Patients With Type 1 Diabetes
NCT02733211 ·Status: WITHDRAWN ·Phase: NA
-
Dexcom Hybrid Closed Loop Insulin Pump Study in Type 1 Diabetes
NCT05059860 ·Status: COMPLETED
-
Cohort Study to Refine the Positioning of Closed-loop Therapy Versus Islet Transplantation in the Management of Patients With Unstable Type 1 Diabetes
NCT07006272 ·Status: RECRUITING
-
Insulin Degludec Titration Using Mobile Insulin Dosing System
NCT03091712 ·Status: COMPLETED ·Phase: NA
-
The International Diabetes Closed Loop (iDCL) Trial: Clinical Acceptance of the Artificial Pancreas
NCT03563313 ·Status: COMPLETED ·Phase: NA
-
Obtain a Good Blood Glucose Control With the Paradigm Real Time System
NCT00441129 ·Status: COMPLETED ·Phase: NA
-
Project Nightlight: Efficacy and System Acceptance of Dinner/Night vs. 24hr Closed Loop Control
NCT02679287 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Automated Insulin Therapy Early Initiated After Diagnosis on Blood Glucose Control in Children and Adolescents With Type 1 Diabetes
NCT06283797 ·Status: RECRUITING ·Phase: NA
-
Pilot Study 3 of Outpatient Control-to-Range: Safety and Efficacy With Day-and-Night In-Home Use
NCT02137512 ·Status: COMPLETED ·Phase: NA
-
Tandem Predictive Low Glucose Suspend Inpatient Feasibility Study
NCT02877771 ·Status: COMPLETED ·Phase: PHASE1
-
Study the Feasibility of Permanent Use of inControl for the Treatment of Type 1 Diabetes
NCT02892604 ·Status: TERMINATED ·Phase: NA
-
Sensor-augmented Pump Versus Multiple Daily Injections With Degludec as Basal Insulin for Insulin Therapy in Type 1 Diabetes
NCT03557892 ·Status: COMPLETED ·Phase: NA